Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30048986HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048987HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048988HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048989HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS30048990HIVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS20007615HPVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TVIS20053922HPVENSG00000105486.15protein_codingLIG1NoNo3978F5GZ28
P18858
TCGA Plot Options
Drug Information
GeneLIG1
DrugBank IDDB01280
Drug NameNelarabine
Target IDBE0000199
UniProt IDP18858
Regulation Typeinhibitor
PubMed IDs18035189; 18473971
CitationsBuie LW, Epstein SS, Lindley CM: Nelarabine: a novel purine antimetabolite antineoplastic agent. Clin Ther. 2007 Sep;29(9):1887-99.@@Curbo S, Karlsson A: Nelarabine: a new purine analog in the treatment of hematologic malignancies. Rev Recent Clin Trials. 2006 Sep;1(3):185-92.
GroupsApproved; Investigational
Direct ClassificationPurine nucleosides
SMILESCOC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
Pathways
PharmGKBPA164752425
ChEMBLCHEMBL1201112